Cargando…
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Despite recent advances in diagnosis and treatment, glioblastoma (GBM) represents the most common and aggressive brain tumor in the adult population, urging identification of new rational therapeutic targets. Galectins, a family of glycan-binding proteins, are highly expressed in the tumor microenvi...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745137/ https://www.ncbi.nlm.nih.gov/pubmed/35008740 http://dx.doi.org/10.3390/ijms23010316 |